Patent details

Basic Information

Publication number:

EP1255564

PCT Application Number:

PCT/EP/01/01744

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019276740

PCT Publication Number:

WO/01/06034

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION COMPRISING SQUALENE EPOXIDASE INHIBITOR AND MACROLIDE IMMUNOMODULATOR

French Title of Invention:

COMPOSITION PHARMACEUTIQUE CONTENANT UN INHIBITEUR DE LA SQUALENE EPOXYDASE ET UN IMMUNOMODULATEUR MACROLIDIQUE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EINEN SQUALENEPOXIDASEHEMMER UND EINEN MAKROLID-IMMUNOMODULATOR

SPC Number:

Dates

Filing date:

16/02/2001

Grant date:

12/11/2003

EP Publication Date:

12/11/2003

PCT Publication Date:

23/08/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/11/2002

EP B1 Publication Date:

12/11/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/02/2004

Expiration date:

16/02/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/02/2001

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4002 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

MAYER Friedrich, Karl

Address:

Switzerland (CH)

2

Name:

RYDER Neil, Stewart

Address:

Austria (AT)

Priority

Priority Number:

0003932

Priority Date:

18/02/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 45/06;

Filing date	Document type	Number of pages